verapamil has been researched along with Hypersensitivity in 5 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menciu, C | 1 |
| Duflos, M | 1 |
| Fouchard, F | 1 |
| Le Baut, G | 1 |
| Emig, P | 1 |
| Achterrath, U | 1 |
| Szelenyi, I | 1 |
| Nickel, B | 1 |
| Schmidt, J | 1 |
| Kutscher, B | 1 |
| Günther, E | 1 |
| Nunes, IKDC | 1 |
| de Souza, ET | 1 |
| Martins, IRR | 1 |
| Barbosa, G | 1 |
| Moraes Junior, MO | 1 |
| Medeiros, MM | 1 |
| Silva, SWD | 1 |
| Balliano, TL | 1 |
| da Silva, BA | 1 |
| Silva, PMR | 1 |
| Carvalho, VF | 1 |
| Martins, MA | 1 |
| Lima, LM | 1 |
| Norn, S | 1 |
| Jensen, C | 1 |
| Stahl Skov, P | 1 |
| Kessel, M | 1 |
| Gieseler, F | 1 |
| Woodcock, BG | 1 |
| Chand, N | 1 |
| Pillar, J | 1 |
| Diamantis, W | 1 |
| Sofia, RD | 1 |
5 other studies available for verapamil and Hypersensitivity
| Article | Year |
|---|---|
New N-(pyridin-4-yl)-(indol-3-yl)acetamides and propanamides as antiallergic agents.
Topics: Acetylcholine; Animals; Anti-Allergic Agents; Bronchoalveolar Lavage; Capillary Permeability; Carbac | 1999 |
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; H | 2020 |
In vivo and in vitro inhibition of histamine release by calcium antagonists.
Topics: Basophils; Cladosporium; Histamine Release; Humans; Hypersensitivity; Nifedipine; Reference Values; | 1983 |
Influence of serum protein binding on the uptake and retention of idarubicin by sensitive and multidrug resistant human leukemic cells.
Topics: Anti-Arrhythmia Agents; Blood Proteins; Cell Line; Drug Resistance, Multiple; Humans; Hypersensitivi | 1999 |
In vitro inhibition of allergic histamine release by calcium antagonists.
Topics: Animals; Basophils; Calcium Channel Blockers; Histamine Release; Hypersensitivity; In Vitro Techniqu | 1985 |